ArticleCardiovascular diabetology2024

Liraglutide and not lifestyle intervention reduces soluble CD163 after comparable weight loss in obese participants with prediabetes or type 2 diabetes mellitus.

Helene Grannes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.